These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7094363)

  • 21. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
    Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
    Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome.
    Nishida S; Matsumura S; Horino M; Oyama H; Tenku A
    Steroids; 1976 Sep; 28(3):411-21. PubMed ID: 982498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cortisol levels in Cushing's syndrome after low- and high-dose dexamethasone suppression.
    Ashcraft MW; Van Herle AJ; Vener SL; Geffner DL
    Ann Intern Med; 1982 Jul; 97(1):21-6. PubMed ID: 6212010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone infusion testing in the diagnosis of Cushing's syndrome.
    Tran HA; Petrovsky N
    Endocr J; 2005 Feb; 52(1):103-9. PubMed ID: 15758565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with a simple screening test for Cushing's syndrome combining the determination of plasma cortisol circadian rhythm with the overnight dexamethasone suppression test.
    Reschini E; Giustina G
    Am J Med Sci; 1978; 275(1):33-42. PubMed ID: 665710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of reference values for endocrine tests. I: Cushing's syndrome.
    de Bos Kuil MJ; Endert E; Fliers E; Prummel MF; Romijn JA; Wiersinga WM
    Neth J Med; 1998 Oct; 53(4):153-63. PubMed ID: 9825640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overnight dexamethasone pre-treatment improves the performance of the lysine-vasopressin test in the diagnosis of Cushing's syndrome.
    Contreras P; Araya V
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):703-10. PubMed ID: 8759183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome.
    Atkinson AB; McAteer EJ; Hadden DR; Kennedy L; Sheridan B; Traub AI
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):753-9. PubMed ID: 2728813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary cortisol for the evaluation of Cushing's syndrome.
    Luthold WW; Marcondes JA; Wajchenberg BL
    Clin Chim Acta; 1985 Sep; 151(1):33-9. PubMed ID: 4042369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome.
    Weber A; Trainer PJ; Grossman AB; Afshar F; Medbak S; Perry LA; Plowman PN; Rees LH; Besser GM; Savage MO
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):19-28. PubMed ID: 7641408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.